U.S. Surgeon General Dr. Vivek Murthy told CNBC on Wednesday there is reason to be hopeful that people who received the single-shot Johnson & Johnson Covid-19 vaccine may be protected against the virus' Delta variant.
Murthy pointed to data that showed the Oxford-AstraZeneca shot is highly effective against hospitalization from the more contagious variant.
He also said people should think of the AstraZeneca vaccine "as a cousin" to J&J's shot since it was "built on a similar platform
No comments:
Post a Comment